GeorgeSomloMD

Clinical Trials

• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma Start of enrollment: 1994 Sep 01

  Completed

  Phase 2

• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer Start of enrollment: 1994 Dec 01

  Completed

  Phase 1

• Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer Start of enrollment: 1997 May 30

  Active, not recruiting

  Phase 2

• Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer Start of enrollment: 1999 May 18

  Completed

  Phase 1

• Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma Start of enrollment: 1999 Apr 13

  Completed

  Phase 2

• Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer Start of enrollment: 1999 May 01

  Completed

  Phase 2

• Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2004 Jan 01

  Completed

  Phase 1, Phase 2

• Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma Start of enrollment: 2004 Nov 01

  Completed

  Phase 1, Phase 2

• Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer Start of enrollment: 2005 Jul 01

  Completed

  Phase 2

• Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer Start of enrollment: 2008 Dec 02

  Completed

  Phase 2

• Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer Start of enrollment: 2008 Sep 04

  Completed

• Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01

  Completed

  Phase 3

• MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer Start of enrollment: 2009 Nov 01

  Completed

• Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 Apr 20

  Active, not recruiting

  Phase 2

• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer Start of enrollment: 2012 Feb 15

  Active, not recruiting

  Phase 2

• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer Start of enrollment: 2013 Jul 17

  Active, not recruiting

  Phase 2

• S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01

  Terminated

  Phase 3

• Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer Start of enrollment: 2016 Mar 28

  Completed

  Phase 2

• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles Start of enrollment: 2017 Apr 28

  Recruiting

• Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma Start of enrollment: 2018 Jan 01

  Withdrawn

  Phase 1, Phase 2

• Join now to see all